Quick Answer
AbbVie Inc. reported Diluted EPS of $2.36 per share for fiscal year 2025.
AbbVie Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.36 | -1.3% |
| 2024 | $2.39 | -12.1% |
| 2023 | $2.72 | -59.0% |
| 2022 | $6.63 | +2.8% |
| 2021 | $6.45 | +137.1% |
| 2020 | $2.72 | -48.5% |
| 2019 | $5.28 | +44.3% |
| 2018 | $3.66 | +10.9% |
| 2017 | $3.30 | -9.1% |
| 2016 | $3.63 | +16.0% |
| 2015 | $3.13 | +184.5% |
| 2014 | $1.10 | -57.0% |
| 2013 | $2.56 | -23.6% |
| 2012 | $3.35 | +53.7% |
| 2011 | $2.18 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.10 | -88.6% | -80.8% |
| June 30, 2025 | $0.52 | -32.5% | -27.8% |
| March 31, 2025 | $0.72 | -6.5% | -18.2% |
| September 30, 2024 | $0.88 | -12.0% | +14.3% |
| June 30, 2024 | $0.77 | -32.5% | +0.0% |
| March 31, 2024 | $0.77 | +492.3% | -23.0% |
| September 30, 2023 | $1.00 | -54.8% | -12.3% |
| June 30, 2023 | $1.14 | +123.5% | +776.9% |
- AbbVie Inc. showed a decrease of -1.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2011–2025 period, AbbVie Inc.’s diluted eps has grown by 8.3% (from $2.18 per share to $2.36 per share).
- The most recent figure is from AbbVie Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: